About the ETRO Studies

Have Questions? Find Answers.

We are a team of dedicated healthcare professionals working toward developing the next path to treatment for Ulcerative Colitis (UC) and Crohn’s disease. Though we believe our research has brought us close to identifying a potential new medication, we cannot do it without you. A clinical study involves a lot of different people, and your participation is crucial to our success.

Is the study open to people who have had surgery?

Potential study participants who have had extensive colonic resection, subtotal or total colectomy, past or present ileostomy or colostomy, or planned surgery for UC, are not eligible for these studies. Your study team can answer more specific questions about the requirements for participating in these studies for people with moderately to severely active UC or Crohn’s.

Are minors (under the age of 18) able to participate in the study?

No, the study is open to participants between the ages of 18 and 80.

Where are the study locations and can someone participate if they are not near a study location?
Study locations vary. To learn more about the study locations, speak to one of our Trial Information Support Nurses or take the quiz to see if you might be eligible and if there is a study site near you.
After completing the pre-screener, how can someone find out if they may be eligible to participate in the study?

Once you complete the pre-screener, an Etro Trial Support Nurse will call you to discuss with you if the Etro Studies might be right for you. Ultimately, the staff at the study location determines whether you may be eligible to participate. Nurses are available Monday – Friday, 6am – 3pm Pacific time.

Can people find out the results of the studies?

Genentech, the sponsor of these studies, is committed to publishing all scientifically and clinically relevant information from clinical trials promptly. One of our goals is to give healthcare professionals and participants a balanced and scientific overview of how our study medications perform in trials.

What is the next step if the studies prove to be successful?

If there are positive results, the study sponsor (the company that is developing the investigational medicine) will apply to the regulatory agency in each country for approval for use in the specified disease population.

Interested in taking part in the Etro Studies? Find out if the Etro Studies could be right for you.

 

  • Print